A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

B G Feagan, Laurent Peyrin‐Biroulet, Silvio Danese et al.|Journal of the Canadian Association of Gastroenterology|2021

Cited by 8